breast cancer
Resident studies outcomes of neoadjuvant therapy for UNMC breast cancer patients
Nila Jones, MD, a second-year resident in UNMC’s Department of Pathology, Microbiology and Immunology, is taking a comprehensive look at patient outcomes of neoadjuvant breast cancer therapy for UNMC patients between 2014 and 2024.
Jun 25, 2025
